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Abstract
Background: Sleep disturbances have been reported in obsessive-compulsive disorder (OCD) patients, with
heterogeneous results. The aim of our study was to assess sleep function in OCD and to investigate the relationship
between sleep and the severity of obsessive-compulsive (OC) symptoms, depressive symptoms and trait anxiety.
Methods: Sleep quality was measured in 61 OCD patients and 100 healthy controls (HCs) using the Pittsburgh
Sleep Quality Index (PSQI). Multiple linear regression was conducted to explore the association between sleep and
psychopathological measures; a mediation analysis was also performed.
Results: OCD patients showed poor sleep quality and more sleep disturbances compared to HCs. The severity of
depression, trait anxiety and OC symptomatology were correlated with poor sleep quality. Multiple linear regression analyses
controlling for potential confounders revealed that the severity of depression and trait anxiety were independently related to
poor sleep quality in OCD. A mediation analysis showed that both the severity of trait anxiety and depression mediate the
relationship between the severity of OC symptoms and poor sleep quality among patients with OCD.
Conclusions: Our findings support the existence of sleep disturbances in OCD. Trait anxiety and depression play a key role
in sleep quality among OCD patients.
Keywords: Obsessive-compulsive disorder, Sleep disorders, Sleep quality, Delayed sleep phase disorder, Depression, Trait
anxiety
Background
Sleep is crucial to brain function and important for
maintaining cognitive and emotional processes [1]. Sleep
disturbances have been reported in mood, eating, anx-
iety, personality, autism and schizophrenia disorders [2].
In major depressive disorder (MDD), insomnia or hyper-
somnia are considered one of the DSM-5 diagnostic
criteria, and specifically, some sleep patterns measured
by polysomnography (PSG), such as a decrease in slow-
wave sleep (SWS) production and disturbed rapid eye
movement (REM) sleep regulation, have been proposed
as biological markers for depression [3].
Sleep disturbances are also prevalent in obsessive-
compulsive disorder (OCD), as up to 48% of patients re-
port these disturbances [4]. Previous research in OCD
suggests that there is an association between specific
sleep behaviours and clinical characteristics such as the
severity of obsessive-compulsive (OC) symptoms, treat-
ment resistance and age of onset of the disorder [5, 6].
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Similarly, correlations between sleep disturbances, OC
symptoms and response inhibition have been observed
in subclinical samples [7, 8]. On the other hand, some
studies argue that sleep disturbances in OCD could be
attributed to the presence of comorbid depression [9–
11].
Sleep disturbances in OCD have been studied with dif-
ferent measures, including self-report, observer report
and PSG. Findings in this area could be classified into
different groups: sleep quantity and quality, sleep disor-
ders and sleep architecture.
The most reported disturbances in OCD compared to
healthy controls (HCs) are the reduction in sleep dur-
ation and efficiency and increased nighttime awakenings
[12–14]. Moreover, poorer sleep quality has been associ-
ated with the severity of OCD symptoms [15]. In con-
trast, another study that compared sleep function among
four groups of subjects: OCD with and without comor-
bid depression, depressed patients and HCs [9] reported
no differences in sleep function between OCD patients
without comorbid depression and HCs, while OCD pa-
tients with depression and depressed patients exhibited
very similar sleep patterns. These findings suggest the
influence of comorbid depression on sleep quantity and
quality. In line with these observations, two recent meta-
analyses [10, 11] revealed that comorbid depression is a
key factor in the existence of sleep disturbances in OCD,
except for shortened sleep duration and longer sleep la-
tency, which seem to be independent of comorbid
depression.
Delayed sleep phase disorder (DSPD), which is consid-
ered a circadian sleep disorder (DSM-5), is a persistent
inability to fall asleep coupled with extreme difficulty
awakening in the morning. Several studies reported a
higher prevalence of DSPD in OCD (17.6–42%) com-
pared to the general population (0.2–10%) [5, 6, 16].
OCD patients with DSPD had more severe OC symp-
tomatology and younger age at onset than patients with-
out DSPD [5, 6]. The influence of depression on sleep
circadian rhythm is unclear. Bobdey et al. [9] described
DSPD in a subgroup of OCD patients without depres-
sion, supporting DSPD as a characteristic sleep behav-
iour in OCD; however, a recent meta-analysis reported a
significantly higher prevalence of DSPD in OCD com-
pared to HCs, but this effect became nonsignificant after
controlling for comorbid depression [11].
In relation to sleep architecture in OCD, several stud-
ies identified alterations in REM and no-REM phase [12,
13, 17]. However, the results of a recent meta-analysis
only revealed significant findings in a no-REM phase, de-
scribing a statistically significant reduction in the time
spent in stage-2 sleep in OCD compared to HCs [10].
As it is described above, several studies have reported
the influence of intensity of depression and OC
symptomatology on the sleep function of OCD patients.
However, up to date, no association between anxiety and
sleep behaviour in these patients has been reported.
Anxious traits have been related to sleep disruptions in
the general population and in individuals with anxiety
disorders such as panic disorder and posttraumatic
stress disorder [18]. Alterations in sleep architecture are
associated with both state anxiety (defined as a tempor-
ary reaction to adverse events) and trait anxiety (a more
stable personality feature defined as a constant individ-
ual difference related to the tendency to respond with
concerns, troubles and worries to various situations) [19]
in patients with sleep disorders. In particular, trait anx-
iety was associated with poor sleep quality in a non-
clinical sample [20].
The aim of our study was to assess the differences in
sleep pattern and quality in patients with OCD com-
pared to HCs and to determine the influence of the se-
verity of depressive, trait anxiety and OC symptoms on
sleep function in the patient group. Our hypothesis was
that OCD patients would show worse sleep function
(poor sleep quality and DSPD) than controls. We also
aimed to determine whether the severity of psychopath-
ology (depression and trait anxiety) could mediate the




The sample comprised 161 participants: 61 outpatients
with OCD and 100 HCs. All patients were recruited
from consecutive admissions to the Obsessive-
Compulsive Disorders Unit of Bellvitge University Hos-
pital (L’Hospitalet de Llobregat; Barcelona). HCs were
recruited from the same geographic area through adver-
tisements. The exclusion criteria were as follows: a his-
tory of substance abuse and/or dependence (except
nicotine); other DSM-IV-TR Axis I and II comorbid psy-
chiatric disorders except for MDD; neurological disease
(except tics); having suffered a head injury with loss of
consciousness; severe medical conditions; mental retard-
ation; a history of bipolar disorder; a history of psychotic
episodes; and having undergone electroconvulsive ther-
apy and/or neurosurgery.
Written informed consent was obtained from each par-
ticipant after a complete description of the study, which
was approved by the Comitè Ètic d’Investigació Clínica
(CEIC) de l’Hospital Universitari de Bellvitge. The authors
assert that all procedures described herein comply with
the Helsinki Declaration of 1975 (revised in 2013).
Clinical assessment
Patients were diagnosed by an experienced psychiatrist
using the Mini-International Neuropsychiatric Interview
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(MINI) [21] and met the DSM-IV-TR diagnosis criteria
for OCD. Twenty-six OCD patients (42.6%) showed de-
pression comorbidity.
The current or past history of psychiatric or neuro-
logical disorders, treatment with psychotropic medica-
tion, substance dependence or abuse, and head injury
were ruled out in HCs by a semi-structured interview
conducted by an experienced psychiatrist. All HCs also
scored below 7 on the 28-item Spanish adaptation of the
Goldberg General Health Questionnaire (GHQ-28) [22].
Patients received psychopharmacological treatment at
the time of the sleep assessment following their clinical
needs (98.4% of the sample). The World Health
Organization Anatomical Therapeutic Chemical Classifi-
cation System [23] was used to recode the defined daily
dose (DDD) of antidepressant medication. DDD can be
defined as the assumed average maintenance dose per
day for drug use for its main indication in adults. Anti-
psychotic and benzodiazepine treatments were also reg-
istered, and doses were recorded in chlorpromazine
equivalents for antipsychotic drugs [24] and in diazepam
equivalents for benzodiazepines (equivalent doses ob-
tained from the Ashton Manual, available at https://
www.benzo.org.uk/manual/index.htm).
Sociodemographic variables such as sex, age and edu-
cational level were collected for all participants, and age
of onset of OCD was collected in the patient group.
Symptom measures
Depression was measured with the 17-item Hamilton
Depression Rating Scale (HDRS) [25], and trait-related
anxiety was measured with the Trait Subscale of the
State-Trait Anxiety Inventory (STAI) [26], in all the
sample. The internal consistency of the HDRS in our
sample was good (Cronbach’s alpha = 0.81). Both STAI-
state and STAI-trait subscales showed excellent internal
consistency (Cronbach’s alpha was 0.96 and 0.95, re-
spectively). In the patient group, OCD severity was mea-
sured using the clinical version of the Yale-Brown
Obsessive-Compulsive Scale (Y-BOCS) [27]. The in-
ternal consistency of the Y-BOCS was excellent (Cron-
bach’s alpha = 0.91).
Sleep function measures
Sleep function was assessed using the Pittsburgh Sleep
Quality Index (PSQI) [28]. The PSQI is a retrospective
self-report questionnaire that evaluates sleep function in
the previous month and includes twenty-four self-
related items, although only nineteen were used to cal-
culate sleep quality that resulted in seven components
(subjective sleep quality, sleep latency, sleep duration,
habitual sleep efficiency, sleep disturbances, use of sleep-
ing medication and daytime dysfunction). Each of them
scored equally on a 0–3 score (the higher the score, the
worse sleep quality). These components are as follows.
A global PSQI score > 5 suggests poor sleep quality. In
addition, specific items that would be useful to evaluate
early insomnia and sleep phase shifting (SPS) were
assessed: 1) the average amount of time a subject spends
between going to bed and falling asleep; 2) usual bed-
time; and 3) usual getting-up time. SPS was measured
with the same procedure as described by Bobdey et al.
[9]: the midpoint between bedtime and getting-up time
for each subject was obtained (for example, if an individ-
ual went to bed at 23:00 h and got up at 06:00, their
midsleep point would be 02:30). Mid-sleep is a chrono-
type indicator, with people from the morning type
reporting earlier mid-sleep times when compared to
people from the evening type, who report later mid-
sleep times.
The internal consistency of the PSQI in our sample
was good (Cronbach’s alpha = 0.79).
Statistical analysis
Data processing was performed using SPSS 21.0 (SPSS,
IBM, USA). Differences in demographic, clinical and
sleep variables between OCD patients and HCs were
assessed by comparing the means using Student’s t test
for continuous variables, the X2 test for a linear trend
for ordinal variables and the X2 test for categorical vari-
ables. As sleep measures were not distributed normally,
we used the Spearman correlation analysis to explore
the relationship between continuous clinical variables
and sleep function. Consequently, the global PSQI score
was log transformed (ln) with the following formula:
lnPSQI = ln (PSQI+ 1). A multiple linear regression was
performed to explore the relationship between OCD and
sleep function (lnPSQI) after adjusting for clinical vari-
ables. The transformed global PSQI score was consid-
ered the dependent variable. Other covariates (sex, age,
the severity of depression, trait anxiety, obsessive-
compulsive symptomatology, benzodiazepine treatment
doses and comorbidity with MDD) were included as in-
dependent variables.
The Process macro for SPSS [29] was used to conduct
a mediation analysis. This macro allows the inclusion of
multiple mediators and covariates. In this mediation
analysis, we decided to include the Y-BOCS score as the
main independent variable because the severity of OCD
might affect sleep function and can also be associated
with other psychopathology variables (depressive symp-
toms and trait anxiety) that can affect sleep function as
well. The global PSQI score (ln) was used as the
dependent variable. Two potential mediators were con-
sidered: severity of depression (HDRS) and trait anxiety.
The significance of the indirect effects in this model was
tested by bootstrapping. In brief, bootstrapping is a non-
parametric method based on resampling with
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replacement, which is performed many times. It allows
the generation of the indirect effect and a confidence
interval (CI) of the bootstrapped distribution. If zero is
not in the confidence interval, then the researcher can
be confident that the indirect effect is different from
zero and mediation exists.
Results
Demographic and clinical characteristics
Table 1 describes the demographic and clinical charac-
teristics of the sample. As expected, OCD patients re-
ported more psychopathology symptoms than HCs.
OCD patients with depression reported more depressive
symptoms but no significant differences in trait anxiety
or OC symptoms when compared with OCD patients
without depression. No significant differences in anti-
depressant or antipsychotic treatment were found in pa-
tients with or without MDD (Table 2), although the
latter group received more benzodiazepines.
Sleep quality
OCD patients reported poorer sleep quality than HCs
(Table 3 and Table 4), with significant differences in
sleep latency, sleep disturbance, use of sleeping medica-
tion and daytime dysfunction. OCD patients reported
more time between going to bed and falling asleep as
well as later times for getting up than HCs (Table 4). Re-
garding SPS, OCD patients showed significantly later
mid-sleep points compared to HCs. No statistically dif-
ferences in sleep quality measures and SPS were ob-
served between OCD patients with and without MDD
comorbidity, an additional table file shows this in more
detail (Supplementary Table 1).
Correlation analyses
In OCD patients, higher scores on the PSQI, which re-
flect worse sleep quality, were positively associated with
the severity of depression, trait anxiety and OC symp-
tomatology (Table 5). No associations were found be-
tween the mid-sleep point, age at assessment and age of
onset of OCD and sleep function and any clinical
variables.
In HCs, poor sleep quality was positively associated
with the severity of depression symptoms and trait anx-
iety and earlier mid-sleep points (morning chronotype)
(Table 5).
Predictors and mediating factors influencing sleep quality
The results of the multiple regression model for the glo-
bal PSQI score are shown in Table 6. After adjusting for
clinical variables (sex, age, the severity of depression,
trait anxiety, obsessive-compulsive symptomatology,
benzodiazepine treatment doses and comorbidity with
MDD), only higher levels of depression and trait anxiety
in OCD patients were associated with worse sleep
quality.
In the mediation analyses (Fig. 1), the severity of de-
pression and trait anxiety were analysed as two potential
mediators in the relationship between the intensity of
OC symptomatology and sleep function. In the un-
adjusted model (a), the intensity of OC symptoms was
positively associated with PSQI scores. This effect was
fully mediated by both the severity of trait anxiety and
depression (b); similarly, that the relationship between
the intensity of OC symptomatology and sleep function
was no longer significant when these two mediators
were included in the equation. This mediation analysis
was adjusted for the following clinical variables: age (β =
− 0.003, SE = 0.007, P = 0.60), sex (β = − 0.11, SE = 0.15,
Table 1 Demographic and clinical characteristics of the sample
OCD HC
N % N % Statistic df P value
Sex
Male 35 57.4 51 51 X2 = 0.61 1 0.43
Female 26 42.6 49 49
Mean SD Mean SD Statistic df P value
Age (years) 42.87 11.32 44.03 14.91 t = 0.52 159 0.60
Education (years) 12.77 3.81 13.50 4.02 t = 1.14 159 0.26
HAM-D-17 8.10 5.22 0.69 1.11 t = −13.7 159 < 0.001*
Y-BOCS 22.37 5.40 –
STAI-Trait 34.93 11.43 13.18 8.31 t = −13.94 159 < 0.001*
STAI-State 26.26 14.96 10.44 6.94 t = −9.04 156 < 0.001*
Abbreviations: OCD Obsessive-Compulsive Disorder, HC Healthy Controls, SD Standard Deviation, HAM-D Hamilton Depression Rating Scale, Y-BOCS Yale-Brown
Obsessive Compulsive Scale, STAI State-Trait Anxiety Inventory
*P < 0.05
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P = 0.47), and benzodiazepine doses (β = 0.005, SE =
0.01, P = 0.56). The bootstrapping results for indirect ef-
fects were significant for depressive symptoms (95% CI:
0.005 to 0.045) and trait anxiety (95% CI: 0.003 to
0.042).
Discussion
Patients with OCD reported poorer sleep quality and
more sleep disturbances, including a delayed mid-sleep
point and a longer time between going to bed and falling
asleep, than HCs. Furthermore, the severity of depres-
sion and trait anxiety was associated with poorer sleep
quality and mediated the relationship between the sever-
ity of OC symptoms and poorer sleep quality. Although
previous studies had reported the contribution of de-
pressive symptoms to poor sleep quality in OCD, our
study is the first to highlight the additional contribution
of trait anxiety on sleep quality in OCD patients.
The findings in longer sleep latency, measured as a
component of PSQI and registering the time taken to fall
asleep, in OCD patients replicate previous studies using
self-report measures [9], as well as a meta-analysis of
three studies conducted with PSG [10]. On the other
hand, the lack of differences in sleep duration and sleep
efficiency between both groups appears to contradict
other reports with positive results [12–14], although in
these studies, variations in sleep duration and sleep effi-
ciency were determined using PSG. Therefore, discrep-
ancies with these findings might be attributable to the
use of different instruments to evaluate sleep function,
as the PSQI does not correlate well with PSG [28], which
is considered the gold standard objective measure of
sleep. In addition, a subgroup of OCD patients with





Statistic df P value
Clinical Variables
HAM-D-17 6.67 (4.22) 10.04 (5.87) t = −2.62 59 0.01*
Y-BOCS 22.55 (6.06) 22.13 (4.46) t = 0.29 59 0.77
STAI-Trait 35.11 (9.82) 34.7 (13.50) t = 0.14 59 0.89
STAI-State 26.40 (14.40) 26.04 (16.11) t = 0.09 59 0.93
Psychopharmacological Treatment Doses (DDD)
SSRI 3 (1.80) 3.12 (2.44) t = −0.21 59 0.83
Dual-action antidepressants 0.09 (0.35) 0.38 (0.91) t = −1.72 59 0.09
TCA 0.66 (0.91) 0.65(0.90) t = 0.07 59 0.95
Other antidepressants 0.01 (0.08) 0.04 (0.20) t = −0.65 59 0.52
Benzodiazepines (diazepam equivalents mg/day) 3.47 (6.75) 8.44 (9.35) t = −2.41 59 0.02*
Antipsychotics (chlorpromazine equivalents mg/day) 64.86 (116.22) 52.31 (109.70) t = 0.43 59 0.67
Data are mean (SD). Abbreviations: OCD Obsessive-Compulsive Disorder, MDD Major Depressive Disorder, HAM-D Hamilton Depression Rating Scale, Y-BOCS Yale-
Brown Obsessive Compulsive Scale, STAI State-Trait Anxiety Inventory, DDD defined daily doses, SSRI selective serotonin reuptake inhibitors, TCA
tricyclic antidepressants
*P < 0.05
Table 3 Pittsburgh Sleep Quality Index: scores and components’ descriptive analyses
PSQI component Score 0 Score 1 Score 2 Score 3 Statistic df P value

















Subjective sleep quality 14 (23%) 35 (35%) 24 (39.3%) 54 (54%) 16 (26.2%) 8 (8%) 7 (11.5%) 3 (3%) X2 = 11.98 3 0.001*
Sleep latency 16 (26.2%) 36 (36%) 15 (24.6%) 42 (42%) 11 (18%) 19 (19%) 19 (31.1%) 3 (3%) X2 = 15.38 3 < 0.001*
Sleep duration 36 (59%) 66 (66%) 15 (24.6%) 25 (25%) 6 (9.8%) 7 (7%) 4 (6.6%) 2 (2%) X2 = 2.12 3 0.145
Habitual sleep efficiency 32 (52.5%) 61 (61%) 13 (21.3%) 25 (25%) 8 (13.1%) 7 (7%) 8 (13.1%) 7 (7%) X2 = 2.85 3 0.091
Sleep disturbance 1 (1.6%) 6 (6%) 31 (50.8%) 78 (78%) 25 (41%) 16 (16%) 4 (6.6%) 0 (0%) X2 = 20.60 3 < 0.001*
Use of sleeping medication 35 (57.4%) 86 (86%) 4 (6.6%) 8 (8%) 2 (3.3%) 2 (2%) 20 (32.8%) 4 (4%) X2 = 24.23 3 < 0.001*
Daytime dysfunction 11 (18%) 51 (51%) 20 (32.8%) 41 (41%) 17 (27.9%) 7 (7%) 13 (21.3%) 1 (1%) X2 = 38.25 3 < 0.001*
Abbreviations: OCD Obsessive-Compulsive Disorder, HC Healthy Controls, PSQI Pittsburgh Sleep Quality Index
X2 for a linear trend. *P < 0.05
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comorbid depression reported shorter sleep duration (as
measured with the PSQI) than patients with only OCD,
thus supporting the influence of depression on sleep
duration [9].
The finding that OCD patients have poorer sleep qual-
ity than HCs is partially consistent with the results of
previous studies that used the same instrument (PSQI)
[9, 30]. In contrast, comorbid MDD did not affect poor
sleep quality in our study, whereas Bobdey et al. [9]
found greater sleep disruption (according to the PSQI)
only in OCD patients with comorbid depression com-
pared to patients with only OCD, suggesting that de-
pression substantially influences sleep behaviour.
Multiple systems associated with circadian rhythms
are also related to psychopathology, including functions
on monoaminergic neurotransmitters, the immune sys-
tem, and the hypothalamic-pituitary-adrenal axis [31].
Despite the paucity of studies and the inconsistent find-
ings, a link between circadian rhythm sleep disorder
(CRSD) and OCD has been described. In this sense,
CRSD in OCD is associated with poor treatment re-
sponse, and some preliminary evidence implicates de-
creased light exposure and diurnal symptom variability
in OCD patients [32]. Our results showed a statistically
significant delayed mid-sleep-point and a delay in the
getting-up time in the patient group compared to HCs,
but there were no differences in the sleep bedtime be-
tween both groups. Taking into account that the mid-
sleep point is an indirect measure of DSPD, our findings
replicate the results of previous studies conducted
among patients with OCD [5, 6, 9, 30] and suggest that
circadian rhythms may be disrupted in OCD.
In univariate analyses, the severity of trait anxiety and
depressive and OC symptoms were positively associated
between them and with poor sleep quality. Multivariate
analyses suggest that trait anxiety and depressive symp-
toms (but not OC symptoms) are associated with sleep
quality, although the mediation analysis reveals that both
psychopathological measures mediate the relationship
between OC symptoms and sleep quality. Correlations
between trait anxiety and sleep quality have not been
previously described in OCD, although associations
among depressive symptoms, comorbid MDD and sleep
function have been reported by several studies [9–11,
Table 4 Group mean scores on sleep schedule and global for OCD and HC
OCD HC Statistic df P value
Mean (SD) Mean (SD)
PSQI GS 8.5 (4.8) 4.6 (3.0) t = −6.18 159 < 0.001*
Time falling sleep (min) 35.7 (37.2) 17.7 (18.3) t = −4.1 159 < 0.001*
Sleep bedtime (h:min) 24:16 (1:25) 24:02 (1:22) t = −1.06 159 0.29
Getting-up bedtime (h:min) 8:41 (1:43) 7:58 (1:27) t = −2.81 159 0.005*
Mid-sleep-point (h:min) 4:31 (1:23) 4:03 (1:20) t = −2.09 159 0.04*
Abbreviations: OCD Obsessive-Compulsive Disorder, HC Healthy Controls, SD Standard Deviation, PSQI GS Pittsburgh Sleep Quality Index Global Score, h hour,
min minutes
*P < 0.05
Table 5 Spearman’s correlations between clinical variables and
sleep function in OCD patients and HCs
OCD (61) HC (100)
PSQI PSQI
Age 0.02 0.15





Data represent r coefficient values
Abbreviations: OCD Obsessive-Compulsive Disorder, HCs Healthy Controls, PSQI
Pittsburgh Sleep Quality Index, HDRS Hamilton Depression Rating Scale, Y-
BOCS Yale-Brown Obsessive Compulsive Scale, STAI State-Trait
Anxiety Inventory
*P < 0.05
** P < 0.01
Table 6 Results of the multiple linear regression analyses in







Female Sex −0.09 0.446
MDD 0.04 0.735
BTD 0.06 0.632
lnPSQI was considered the dependent variable
Abbreviations: β Standardized regression coefficient, PSQI Pittsburgh Sleep
Quality Index, Y-BOCS Yale-Brown Obsessive Compulsive Scale, HDRS Hamilton
Depression Rating Scale, STAI-T State-Trait Anxiety Inventory, MDD Major
Depressive Disorder, BTD Benzodiazepine Treatment Doses, lnPSQI Log-
transformed Pittsburgh Sleep Quality Index
*P < 0.05
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13]. Associations between the severity of OC symptoms
and poor sleep quality in our sample are consistent with
the findings of previous studies conducted in OCD pa-
tients [5, 6]. Our study adds new information regarding
the mediating role of trait anxiety and depressive symp-
toms in this relationship.
Previous studies suggest that several clinical character-
istics are associated with CRSD in patients with OCD,
including a younger age, early age of onset of OCD, male
sex and greater severity of OC symptoms [5, 6]. How-
ever, in our sample, we did not find associations between
mid-sleep-point (and indirect measure of DSPS) and age,
age of onset of OCD, sex or the severity of OC
symptoms.
A similar pattern of correlations between clinical vari-
ables and sleep quality was found in HCs, with positive
associations between trait anxiety and depressive symp-
toms and poor sleep quality, suggesting a diagnosis-
independent relationship. Our findings are consistent
with previous studies reporting associations between de-
pressive and anxiety symptoms and sleep disturbances in
college student samples [33] . A systematic review of in-
cluded nine studies conducted in the general population
(excluding clinical samples and cohorts at high risk of
suffering from sleep disturbances, anxiety and depres-
sion) showed a bidirectional relationship between de-
pression/anxiety and several sleep disturbances,
suggesting that alterations in sleep behaviour predicts
depression/anxiety and vice versa [34]. Strikingly, a de-
layed mid-sleep point in HCs was negatively correlated
with higher global PSQI scores, reflecting poor sleep
quality. These findings suggest an association between
an indirect measure of CRSD and general sleep quality
in HCs. Future studies with larger samples are needed
before drawing conclusions regarding this relationship.
Recent findings of neuroimaging studies with func-
tional magnetic resonance imaging (fMRI) reported as-
sociations between decreased connectivity of the left
amygdala and the bilateral region of the anterior cingu-
late cortex and increased risk of developing and anxiety
disorder in patients with primary insomnia [35]. Regard-
ing depression, increased functional connectivity be-
tween different brain areas was associated with both
poor sleep quality and depressive problems score [36].
Therefore, novel results in the field of neuroimaging ex-
plain the neural mechanism underlying the clinically
established associations between sleep function, depres-
sion and anxiety. Similarly, findings from a genetic study
evaluating whether the polygenic score (PGS) for neur-
oticism was related to poor sleep quality showed that
this effect was mediated by anxiety, depressive symp-
toms and neuroticism [37]. These results support prior
clinical and neuroimaging data and reinforce the bio-
logical substrate that might play a role in the relation-
ship between anxiety, depression and sleep behaviour.
Results of a National Comorbidity Survey Replication
Fig. 1 Results of the mediation analysis exploring the relationship between severity of OC symptoms (Y-BOCS) and sleep function (lnPSQI) in
subjects with OCD. Log transformed (ln) of sleep function was used in the mediation analysis. (a) Unadjusted model. The mediated effect
(b) was adjusted for age, sex and benzodiazepines doses. Abbreviations: OC= Obsessive Compulsive; Y-BOCS= Yale-Brown Obsessive Compulsive
Scale; PSQI= Pittsburgh Sleep Quality Index; HDRS= Hamilton Depression Rating Scale; STAI-T= State-Trait Anxiety Inventory; lnPSQI=Log-transformed
(ln) Pittsburgh Sleep Quality Index; β= unstandardized regression coefficient; SE = standard error
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(NCS-R) showed that 90% of patients diagnosed with
OCD met the diagnostic criteria for other lifetime disor-
ders in DSM-IV. Amongst these disorders, the most
common were anxiety disorders (75.8%), followed by
mood disorders (63.3%), impulse-control disorders
(55.9%) and substance use disorders (38.6%) [38]. The
substantial comorbidity of OCD with anxiety and
affective disorders, and the neurobiological relationship
established between anxiety, depression and sleep func-
tion, suggest that sleep disturbances in OCD could be
partly related to the comorbidity with anxiety and de-
pressive disorders. In this regard, a population-based
study evaluated the prevalence of insomnia in OCD and
determined a significant reduction liability to insomnia
when OCD patients with comorbid depression and anx-
iety disorders were excluded from the analysis [39], sug-
gesting that depressive and anxiety disorders contribute
to sleep disturbances in patients with OCD. In line with
the previous studies, the fact that the association be-
tween poor sleep quality and OC symptoms in the uni-
variate analyses in our sample lost its significance when
adjusting for depressive symptoms and trait anxiety sug-
gests that the association with sleep is driven by depres-
sive or anxiety symptoms but not by the severity of OC
symptoms.
The limitations of the current study include a limited
sample size but are nonetheless larger than previous re-
search using the PSQI to assess sleep function in OCD.
We did not include patients with other anxiety or de-
pressive disorders apart from OCD with and without
MDD as a clinical comparison group in our study. Its in-
clusion would have allowed the comparison of sleep pat-
terns between patients suffering from different anxiety
and depressive disorders. Our sample included OCD pa-
tients recruited from a tertiary care facility, thereby lim-
iting the generalization of these results to community
settings. A high percentage of patients (98.4%) was re-
ceiving psychopharmacological treatment at the time of
assessment, which could have a negative effect on sleep
quality, as previous studies have pointed out [4]. In this
regard, some antidepressants commonly-prescribed in
our sample (Selective Serotonin Reuptake Inhibitors
(SSRI) and Tricyclic Antidepressants (TCA)) are sleep-
disturbing early [40] and produce alterations in the
REM-phase [41]. Although the PSQI is a validated in-
strument to assess sleep function [28], it is a self-report
tool and therefore a nonobjective measure of sleep be-
haviour. This condition could introduce the possibility
of a recall bias. The use of mid-sleep points as an indir-
ect measure of DSPS might be improved by incorporat-
ing more extensive and objective measures to assess
circadian rhythm, which allows advancement in the
study of the relationship between OCD and CRSD. Rec-
ommendations to assess CRSD include up to two weeks
of actigraphy recording, measurements of endogenous
melatonin onset and questionnaires of chronotype [42].
Conclusions
On the basis of our findings and taking into account the
limitations of our study, we can conclude that compared
to HCs, patients with OCD show different sleep patterns
characterized by poor sleep quality and more sleep dis-
turbances (delayed mid-sleep-point and higher length of
time between going to bed and falling asleep). Regarding
the influence of clinical variables in sleep function in
OCD, our study suggests that the severity of trait anxiety
and depression symptoms mediate the negative effect of
the intensity of OC symptomatology on sleep quality, in-
dicating that trait anxiety needs to be considered a key
element in sleep function, similar to depression. These
results need to be confirmed by broader studies with
more objective sleep measures to advance the knowledge
of sleep behaviour in OCD and to establish better pre-
vention and intervention strategies.
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